abstract |
The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, n n n n n n n n n n wherein the variables n, p, q, Q, X, X′ and Y are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases. |